Authors' Response to the Letter by Lamarca et al. Entitled "temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration" Regarding "activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms"

Eleftherios Chatzellis; Kosmas Daskalakis; Anna Angelousi; Marina Tsoli; Krystallenia I. Alexandraki; Ewa Wachula; Amichay Meirovitz; Ofra Maimon; Simona Grozinsky-Glasberg; David Gross; Beata Kos-Kudła; Anna Koumarianou; Gregory Kaltsas

doi:10.1159/000503999

Authors' Response to the Letter by Lamarca et al. Entitled "temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration" Regarding "activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms"

Eleftherios Chatzellis, Kosmas Daskalakis, Anna Angelousi, Marina Tsoli, Krystallenia I. Alexandraki, Ewa Wachula, Amichay Meirovitz, Ofra Maimon, Simona Grozinsky-Glasberg, David Gross, Beata Kos-Kudła, Anna Koumarianou, Gregory Kaltsas

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	158-160
Number of pages	3
Journal	Neuroendocrinology
Volume	110
Issue number	1-2
DOIs	https://doi.org/10.1159/000503999
State	Published - 1 Jan 2020
Externally published	Yes

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism
Endocrinology
Endocrine and Autonomic Systems
Cellular and Molecular Neuroscience

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1159/000503999

Cite this

Chatzellis, E., Daskalakis, K., Angelousi, A., Tsoli, M., Alexandraki, K. I., Wachula, E., Meirovitz, A., Maimon, O., Grozinsky-Glasberg, S., Gross, D., Kos-Kudła, B., Koumarianou, A., & Kaltsas, G. (2020). Authors' Response to the Letter by Lamarca et al. Entitled "temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration" Regarding "activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms". Neuroendocrinology, 110(1-2), 158-160. https://doi.org/10.1159/000503999

Chatzellis, Eleftherios ; Daskalakis, Kosmas ; Angelousi, Anna et al. / Authors' Response to the Letter by Lamarca et al. Entitled "temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms : The Dilemma of Treatment Duration" Regarding "activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms". In: Neuroendocrinology. 2020 ; Vol. 110, No. 1-2. pp. 158-160.

@article{5ffa3a1abeef48c1a11cb314ce07c4c2,

title = "Authors' Response to the Letter by Lamarca et al. Entitled {"}temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration{"} Regarding {"}activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms{"}",

author = "Eleftherios Chatzellis and Kosmas Daskalakis and Anna Angelousi and Marina Tsoli and Alexandraki, {Krystallenia I.} and Ewa Wachula and Amichay Meirovitz and Ofra Maimon and Simona Grozinsky-Glasberg and David Gross and Beata Kos-Kud{\l}a and Anna Koumarianou and Gregory Kaltsas",

year = "2020",

month = jan,

day = "1",

doi = "10.1159/000503999",

language = "English",

volume = "110",

pages = "158--160",

journal = "Neuroendocrinology",

issn = "0028-3835",

publisher = "S. Karger AG",

number = "1-2",

}

Chatzellis, E, Daskalakis, K, Angelousi, A, Tsoli, M, Alexandraki, KI, Wachula, E, Meirovitz, A, Maimon, O, Grozinsky-Glasberg, S, Gross, D, Kos-Kudła, B, Koumarianou, A & Kaltsas, G 2020, 'Authors' Response to the Letter by Lamarca et al. Entitled "temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration" Regarding "activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms"', Neuroendocrinology, vol. 110, no. 1-2, pp. 158-160. https://doi.org/10.1159/000503999

Authors' Response to the Letter by Lamarca et al. Entitled "temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration" Regarding "activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms". / Chatzellis, Eleftherios; Daskalakis, Kosmas; Angelousi, Anna et al.
In: Neuroendocrinology, Vol. 110, No. 1-2, 01.01.2020, p. 158-160.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Authors' Response to the Letter by Lamarca et al. Entitled "temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms

T2 - The Dilemma of Treatment Duration" Regarding "activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms"

AU - Chatzellis, Eleftherios

AU - Daskalakis, Kosmas

AU - Angelousi, Anna

AU - Tsoli, Marina

AU - Alexandraki, Krystallenia I.

AU - Wachula, Ewa

AU - Meirovitz, Amichay

AU - Maimon, Ofra

AU - Grozinsky-Glasberg, Simona

AU - Gross, David

AU - Kos-Kudła, Beata

AU - Koumarianou, Anna

AU - Kaltsas, Gregory

PY - 2020/1/1

Y1 - 2020/1/1

UR - http://www.scopus.com/inward/record.url?scp=85077761506&partnerID=8YFLogxK

U2 - 10.1159/000503999

DO - 10.1159/000503999

M3 - Letter

C2 - 31597137

AN - SCOPUS:85077761506

SN - 0028-3835

VL - 110

SP - 158

EP - 160

JO - Neuroendocrinology

JF - Neuroendocrinology

IS - 1-2

ER -

Chatzellis E, Daskalakis K, Angelousi A, Tsoli M, Alexandraki KI, Wachula E et al. Authors' Response to the Letter by Lamarca et al. Entitled "temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration" Regarding "activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms". Neuroendocrinology. 2020 Jan 1;110(1-2):158-160. doi: 10.1159/000503999

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this